Evaluating the difference of skin elasticity value on the use of 3% superoxide dismutase cream and 10% urea


  • Prasetyadi Mawardi Sebelas Maret University
  • Frieda Yanuar Sebelas Maret University


skin elasticity, superoxide dismutase 3%, urea 10%


Introduction: Skin is the outermost layer and the largest organ in the human body which has important role against extrinsic factors such as physical, chemical trauma, and exposure to ultraviolet (UV), which cause damage to its barrier function and induce photoaging, resulting in decreased skin elasticity. Furthermore, urea is a humectant moisturizer that repairs the skin barrier, while superoxide dismutase (SOD) is an antioxidant group commonly used in a series of skin care products.Objective: The study aims to investigate the difference in the value of skin elasticity in the use of 3% SOD and 10% urea cream.Methods: This experimental analytical study was conducted in Dermatotology and Venereology Department outpatient clinic of Dr. Moewardi General Hospital between October-December 2020. Patients with skin disorders and works outdoors were excluded from this study. Superoxide dismutase 3% and urea 10% cream was applied twice daily on the patient's right and left forearm, respectively for a month. Furthermore, the elasticity values of the skin were assessed in week 2 and 4. All data were statistically analyzed with paired t-test and a p value of < 0.05 was considered significant.Results: The results showed that all the subjects (20) had skin elasticity improvement. However, SOD gave a better skin elasticity (p=0.001) than urea cream (p=0.002).Conclusion: Antioxidant SOD cream has better effect in improving skin elasticity compared to urea.


Proksch E, Brandner JM, Jensen JM. The skin: An indispensable barrier. Exp Dermatol. 2008; 17: 1063-72.

Jang HH, Lee SN. Epidermal skin barrier. Asian J Beauty Cosmetol. 2016; 14(3): 339-47.

Yagi M, Yonei Y. Glycative stress and anti-aging: 7. Glycative stress and skin aging. Glycative stress research. 2018; 5(1): 50-4.

Ichihasi M, Yagi M, Nomoto K et al. Glycation stress and photo-aging in skin. Ant-Aging Med. 2011; 8: 23-9.

Ichihasi M, Ando H, Yoshida M, Niki Y, Matsui M. Photoaging of the skin. J anti aging med. 2009; 6(6): 46-59.

Ganceviciene R, Liakou AI, Theodoridis A, Makrantonaki E. Zouboulis C. Skin anti-aging strategies. Dermatoendocrinol. 2012; 4(3): 308-19.

Lodén M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol. 2003; 4(11): 771–88.

John KN, Charles BL, Charles WL. Moisturizers: An essential component in eczema management. Skin ther. 2009; 5(2): 5–7.

Le Quere SM, Lacan D, Lemaire B, Carillon J, Schmitt K. The role of superoxide dismutase (SOD) in skin disorders. Nutrafoods. 2014; 13: 13-27.

Diehl C. A novel efficient and safe treatment for atopic dermatitis: Topical superoxide dismutase (SOD). Dermatol Res Skin Care. 2017; 1(1): 1-7.

Nguyen QL. Cosmetic composition containing a superoxide dismutase and a porphyrin. United States. U.S. Patent Documents. 1990; 19: 3–6.

Elias PM. Skin barrier function. Curr Allergy Asthma Rep. 2008; 8: 299-305.

Kolarsick PAJ, Kolarsick MA, Goodwin C. Skin: Basic structure and anatomy. Dermatol Nurs. 2011; 1(10): 1-12.

Voegeli D. Urea creams in skin conditions: Composition and outcomes. Dermatol in Pract. 2012; 18(3): 13-5.

Addor FAS. Antioxidants in dermatology. An Bras Dermatol. 2017; 92(3): 356-62.

Lods LM, Dres C, Johnson C, Scholz B, Brooks GJ. The future of enzymes in cosmetics. International Journal of Cosmetic Science. 2000; 22: 85-94.

Azadmanesh J, Borgstahl GE. A review of the catalytic mechanism of human manganese superoxide dismutase. Antioxidants. 2018; 25(7): 1-16.

Ighodaro OM, Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alex J Med. 2007; 1-7.

Rhie G, Shin MH, Seo JY, Choi WW, Cho KH, Kim KH et al. Aging and photoaging-dependent changes of enzymic and nonenzymic antioxidants in the epidermis and dermis of human skin in vivo. J Invest Dermatol. 2001; 117: 1212-7.

Simoes SI, Delgado TC, Lopes RM, Jesus S, Ferreira AA et al. Developments in the rat adjuvant arthritis model and its use in therapeutic evaluation of novel non-invasive treatment by SOD in transfersomes. J Control Release. 2005; 103: 419-34.

Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000; 9: 165-9.

Kigasawa K, Miyashita M, Kajimoto K, Kanamura K, Harashima H. Efficient intradermal delivery of superoxide dismutase using a combination of liposomes and iontophoresis for protection against UV-induced skin damage. Biol Pharm Bull. 2012; 35(5): 781-5.

Younus H. Therapeutic potentials of superoxide dismutase. Int J Health Sci. 2018; 12(3): 88-93.




How to Cite

Mawardi P, Yanuar F. Evaluating the difference of skin elasticity value on the use of 3% superoxide dismutase cream and 10% urea. J Pak Assoc Dermatol [Internet]. 2022Apr.10 [cited 2024Jun.17];31(3):387-90. Available from: http://www.jpad.com.pk/index.php/jpad/article/view/1681



Original Articles